Hemogenyx Pharmaceuticals (UK) Price on November 28, 2024
| HEMO Stock | 343.40 20.90 6.48% |
Below is the normalized historical share price chart for Hemogenyx Pharmaceuticals PLC extending back to November 09, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Hemogenyx Pharmaceuticals stands at 343.40, as last reported on the 22nd of December, with the highest price reaching 343.40 and the lowest price hitting 310.00 during the day.
If you're considering investing in Hemogenyx Stock, it is important to understand the factors that can impact its price. Hemogenyx Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0632, which attests that the entity had a -0.0632% return per unit of risk over the last 3 months. Hemogenyx Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hemogenyx Pharmaceuticals' Risk Adjusted Performance of (0.04), standard deviation of 8.04, and Market Risk Adjusted Performance of 0.4359 to validate the risk estimate we provide.
At this time, Hemogenyx Pharmaceuticals' Common Stock Shares Outstanding is comparatively stable compared to the past year. Common Stock is likely to gain to about 12.3 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 2.9 M in 2024. . Hemogenyx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 555.0695 | 50 Day MA 473.294 | Beta 3.256 |
Hemogenyx |
Sharpe Ratio = -0.0632
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HEMO |
Estimated Market Risk
| 8.04 actual daily | 71 71% of assets are less volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Hemogenyx Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hemogenyx Pharmaceuticals by adding Hemogenyx Pharmaceuticals to a well-diversified portfolio.
Price Book 3.9279 | Book Value 0.002 | Enterprise Value 13.2 M | Enterprise Value Ebitda (3.62) | Shares Float 1.2 B |
Hemogenyx Pharmaceuticals Valuation on November 28, 2024
It is possible to determine the worth of Hemogenyx Pharmaceuticals on a given historical date. On November 28, 2024 Hemogenyx was worth 432.0 at the beginning of the trading date compared to the closed value of 470.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Hemogenyx Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Hemogenyx Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hemogenyx Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Hemogenyx Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 388.00 | 439.20 | 340.40 | 428.00 | 20,835,767 | |
11/28/2024 | 432.00 | 500.00 | 400.80 | 470.00 | 7,821,509 |
| 460.80 | 500.00 | 420.80 | 450.40 | 9,152,409 |
| Backtest Hemogenyx Pharmaceuticals | | | Hemogenyx Pharmaceuticals History | | | Hemogenyx Pharmaceuticals Valuation | Previous | Next |
Hemogenyx Pharmaceuticals Trading Date Momentum on November 28, 2024
| On November 29 2024 Hemogenyx Pharmaceuticals PLC was traded for 450.40 at the closing time. The highest price during the trading period was 500.00 and the lowest recorded bid was listed for 420.80 . The volume for the day was 9.2 M. This history from November 29, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 4.17% . The trading delta at closing time to the current price is 12.17% . |
Hemogenyx Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Hemogenyx Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Hemogenyx Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Hemogenyx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Hemogenyx Pharmaceuticals Stock history
Hemogenyx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hemogenyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hemogenyx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hemogenyx Pharmaceuticals stock prices may prove useful in developing a viable investing in Hemogenyx Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.1 B | 1.2 B | |
| Net Loss | -4.6 M | -4.4 M |
Hemogenyx Pharmaceuticals Quarterly Net Working Capital |
|
Hemogenyx Pharmaceuticals Stock Technical Analysis
Hemogenyx Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Hemogenyx Pharmaceuticals Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Hemogenyx Pharmaceuticals PLC cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Hemogenyx Pharmaceuticals December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Hemogenyx Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hemogenyx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Hemogenyx Pharmaceuticals stock market strength indicators, traders can identify Hemogenyx Pharmaceuticals PLC entry and exit signals to maximize returns
Hemogenyx Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Hemogenyx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Hemogenyx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Hemogenyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | 0.4259 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.